We have a strong track record of investing in and supporting MedTech businesses across Europe, North America and Asia and are seeing an increasing number of opportunities to invest in well-established niche operators globally.

A selection of our current and former portfolio includes:

• LHI Technology, a leading manufacturer of patient monitoring and surgical cable interconnects and assemblies. It is the only Asia-based supplier to develop, manufacture and sell medical cables assemblies exclusively to medical device companies and OEMs internationally. The company operates from a high quality manufacturing base in Shenzhen, China and has offices in Japan, Europe and North America. We have introduced 3i sector partner Alberto Bautista as Chairman and 3i’s John Thomson and David Osborne have joined the Board as Non-executive Directors.
• ApaTech, a world leader in synthetic bone graft technology through its lead product Actifuse, targeted at the spinal market. We first invested in 2001 and subsequently led a €29m refinancing to grow ApaTech through expanding commercial operations and manufacturing capacity. In 2008 we introduced senior adviser Peter Chambré as Chairman. ApaTech has operations in London, the US and Germany and was rated the recognised as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review.
• Attends Healthcare Group, the market leader in adult incontinence products to individuals and health organisations. Attends Healthcare Group operates a single production plant in Aneby, Sweden. In addition to production, this site also includes facilities for research & development, product distribution, purchasing, information technology and customer service functions. Our investment allowed the business to focus on innovative product development and Attends is now expanding into selected markets in Central/Eastern Europe and Australasia.